The Diary Of A CEO with Steven Bartlett
379 - Ep. 369 - ASCO advances, China innovation & U.S. science under threat
00:00
00:00
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Épisodes
379-
Ep. 369 - ASCO advances, China innovation & U.S. science under threat
Écouté
378-
Ep. 368 - ASCO Preview, China Policy, ADC Linkers
Écouté
377-
Ep. 367 - FDA, obesity targets and the rise of DACs
Écouté
376-
Ep. 366 - Europe's need for speed: Bio€quity takeaways
Écouté
375-
